Skip to content
  • PAD
    • DETOUR System
    • DETOUR System Reimbursement
    • DETOUR Professional Education
    • For PAD Patients
    • Find a Doctor
  • AAA
    • AAA
    • ALTO
    • AFX2
    • EVAR for Women
    • EVAR Portfolio Resources
    • Clinical Evidence
    • Procedural Training
  • IFU’s
  • About Us
    • About Us
    • News
    • The Team
    • Careers
      • Internal Applicant Portal
      • External Applicant Portal
    • Investigator Initiated
      Research
    • Contact Us
  • PAD
    • DETOUR System
    • DETOUR System Reimbursement
    • DETOUR Professional Education
    • For PAD Patients
    • Find a Doctor
  • AAA
    • AAA
    • ALTO
    • AFX2
    • EVAR for Women
    • EVAR Portfolio Resources
    • Clinical Evidence
    • Procedural Training
  • IFU’s
  • About Us
    • About Us
    • News
    • The Team
    • Careers
      • Internal Applicant Portal
      • External Applicant Portal
    • Investigator Initiated
      Research
    • Contact Us
Back to News
  • October 25, 2016

Endologix Appoints Matthew Thompson, M.D., as Chief Medical Officer

PrevPreviousEndologix Reports Positive Clinical Data from Ovation® LIFE (Least Invasive Fast-Track EVAR) Study
NextEndologix Provides Update on Nellix PMA ProcessNext
FIND IFU HERE
Youtube Linkedin Twitter

Compliance

Privacy Policy

Safety Information

Anti-Trafficking/Modern Slavery

Cookie Policy

Terms & Conditions

Patents

© 2026 Endologix LLC. All rights reserved.

Endologix® products and associated components are not available in all countries or regions. Please contact your Endologix representative for details regarding product availability. Prior to use, refer to the “Instructions for Use” for complete and specificindications, contraindications, all warnings and precautions. Rx only.